WuXi Biologics' CEO Chris Chen has denied that ... will sell its vaccine manufacturing facility in Dundalk, Ireland to Merck & Co. for approximately $500m, the company announced earlier in January.

For a small island of just over 5 million people on Europe's western edge, Ireland is playing an outsize role in the travel ...

If Trump’s talks with Putin facilitate a pause in the fighting, Ukraine will decline in salience as a point of contention ...

MSD and WuXi Biologics – which have been collaborating at Dundalk since 2019 – will now begin an official handover process that aims to be completed in the first half of 2025. Meanwhile ...

WuXi Biologics subsidiary WuXi Vaccines has agreed to sell its vaccine manufacturing facility in Dundalk, Ireland, to MSD for approximately $500m. Expected to close in the first half of 2025 ...

The Investment Promotion & Development Agency (IDA) has revealed mock-up drawings of what the new WuXi Biologics plant in Dundalk might look like - and it is seriously impressive. The Chinese firm ...

WuXi Biologics (stock code: 2269.HK) is a leading global Contract Research, Development and Manufacturing Organization (CRDMO) offering end-to-end solutions that enable partners to discover, develop ...

SHANGHAI, Feb. 10, 2025 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced it has been ...

Hang Zhou, PhD, senior vice president and head of bioprocess research and development , WuXi Biologics. [WuXi Biologics] Raman spectroscopy has become a first-choice PAT for monitoring and ...